Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Experimental Neurology|November 5, 2013
Brain angiotensin regulates iron homeostasis in dopaminergic neurons and microglial cellsPablo Garrido-Gil, Jannette Rodriguez-Pallares, Antonio Dominguez-Meijide, et al.
Brain, Behavior, and Immunity|February 25, 2017
Dopamine modulates astroglial and microglial activity via glial renin-angiotensin system in culturesAntonio Dominguez-Meijide, Ana I Rodriguez-Perez, Carmen Diaz-Ruiz, et al.
Neurobiology of Disease|June 19, 2013
Inhibition of Rho kinase mediates the neuroprotective effects of estrogen in the MPTP model of Parkinson's diseaseAna I Rodriguez-Perez, Antonio Dominguez-Meijide, Jose L Lanciego, et al.
Age (Dordrecht, Netherlands)|September 19, 2012
Dopaminergic degeneration is enhanced by chronic brain hypoperfusion and inhibited by angiotensin receptor blockageAna I Rodriguez-Perez, Antonio Dominguez-Meijide, Jose L Lanciego, et al.
Molecular Neurobiology|February 7, 2018
Bidirectional Neural Interaction Between Central Dopaminergic and Gut Lesions in Parkinson's Disease ModelsPablo Garrido-Gil, Ana I Rodriguez-Perez, Antonio Dominguez-Meijide, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 9, 2013
Dopamine-angiotensin interactions in the basal ganglia and their relevance for Parkinson's diseaseJose L Labandeira-Garcia, Jannette Rodriguez-Pallares, Antonio Dominguez-Meijide, et al.
Neuropharmacology|August 27, 2013
Effect of chronic treatment with angiotensin type 1 receptor antagonists on striatal dopamine levels in normal rats and in a rat model of Parkinson's disease treated with L-DOPAAntonio Dominguez-Meijide, Begoña Villar-Cheda, Pablo Garrido-Gil, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|November 10, 2018
Aging-Related Overactivity of the Angiotensin/AT1 Axis Decreases Sirtuin 3 Levels in the Substantia Nigra, Which Induces Vulnerability to Oxidative Stress and NeurodegenerationCarmen Diaz-Ruiz, Begoña Villar-Cheda, Antonio Dominguez-Meijide, et al.
The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry|October 18, 2014
Rho Kinase and Dopaminergic Degeneration: A Promising Therapeutic Target for Parkinson's DiseaseJose L Labandeira-Garcia, Ana I Rodríguez-Perez, Begoña Villar-Cheda, et al.
Neurobiology of Disease|May 1, 2012
Involvement of microglial RhoA/Rho-kinase pathway activation in the dopaminergic neuron death. Role of angiotensin via angiotensin type 1 receptorsBegoña Villar-Cheda, Antonio Dominguez-Meijide, Belen Joglar, et al.
Pageof 3